Results 91 to 100 of about 62,440 (162)

Proton Pump Inhibitors: How Appropriate?

Canadian Journal of Gastroenterology, 2000
Daniel C Sadowski
doaj   +1 more source

Risk of Depression Related to Use of Proton Pump Inhibitors and Tegoprazan: A Nationwide Cohort Study. [PDF]

J Korean Med Sci
Kim S, Kim JS.
europepmc   +1 more source

Self-medication with proton pump inhibitors among physicians in Bosnia and Herzegovina: a cross-sectional study. [PDF]

Front Med (Lausanne)
Jovanovic P, Bokan G, Basic Denjagic M, Salkic N, Kurtcehajic A, Gavric A, Ljuca K, Tadic M, Mesihovic R, Hauser G, Zerem D.   +10 more
europepmc   +1 more source

Association Between the Use of Proton Pump Inhibitors and Osteoporosis/Fracture: Nested Case-Control Studies Using a National Health Screening Cohort. [PDF]

J Clin Med
Youk H, Park JM, Kim YJ, Park JY, Choi HG, Lee JW.   +5 more
europepmc   +1 more source

Balancing therapeutic benefits and hidden risks of proton pump inhibitors in pediatric practice: a narrative review and update. [PDF]

Clin Exp Pediatr
Rogalidou M, Papadopoulou A.
europepmc   +1 more source

Proton pump inhibitors

World Chinese Journal of Digestology, 2013
Jie-Hao Zhou, Bing-Rong Liu
openaire   +1 more source

The administration of proton pump inhibitors with the CDK4/6 inhibitor abemaciclib does not affect the clinical outcome of metastatic breast cancer patients. [PDF]

Ther Adv Drug Saf
Crucitta S, Cinacchi P, Bargagna I, Biondani P, Giontella E, Palleschi M, Omarini C, Belluzzi L, Angelini L, Meattini I, Visani L, Stucci S, Porta C, Fontana A, De Giorgi U, Fogli S, Danesi R, Del Re M.   +17 more
europepmc   +1 more source

Use of Proton Pump Inhibitors in Infants: Nationwide Cohort Study Based on the French EPI-MERES Register. [PDF]

J Pediatr Clin Pract
Lassalle M, Sebban S, Talbotec C, Dray-Spira R.   +3 more
europepmc   +1 more source

Prophylactic Proton Pump Inhibitors in Critically Ill Patients Undergoing Invasive Ventilation: A Systematic Review and Meta-Analysis of Randomized Trials. [PDF]

Crit Care Res Pract
Hu J, Ye H, Li B, Zheng X.
europepmc   +1 more source

Comparison of the Safety of Proton Pump Inhibitors and Histamine Type 2-Receptor Antagonists in the Prevention of Gastrointestinal Complications. [PDF]

Cureus
Samborska A, Karczewska M, Lichwala K, Szukalska S, Wróblewski K, Siwek L, Balajewicz B.   +6 more
europepmc   +1 more source